Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Intra-Cellular Therapies
Pharma
How J&J CEO broke a stalemate and won Intra-Cellular in M&A push
J&J’s proposed $14.6 billion purchase of Intra-Cellular Therapies was made possible by a key intervention from J&J’s CEO Joaquin Duato, a filing shows.
Angus Liu
Feb 7, 2025 11:24am
J&J acquires CNS specialist Intra-Cellular for $14.6B
Jan 13, 2025 10:29am
Intra-Cellular's unstoppable Caplyta nails another trial
Nov 5, 2024 10:15am
Intra-Cellular closing in on major depression nod for Caplyta
Jun 18, 2024 11:40am
Intra-Cellular moves closer to Caplyta depression expansion
Apr 16, 2024 2:27pm
Intra-Cellular re-ups winning ad as bipolar drug builds momentum
Aug 8, 2023 12:51pm
